ADDIT-CE NeuroConnect Meetup
Date: 27th November, 2025
Time: 3:00 PM – 6:30 PM
Venue: BioVendor Group, Karásek 1767/1, 621 00 Brno
Field: Tackling Alzheimer’s, related dementias, and other neurodegenerative diseases through research, care, and innovation
Why join?
Are you active in Alzheimer’s research, care, technology development, or an investor seeking new healthtech opportunities?
The ADDIT-CE NeuroConnect Meetup brings together innovators, researchers, healthcare providers, companies, and investors to foster collaboration and drive progress in Alzheimer’s, related dementias, and other neurodegenerative diseases.
What to expect
- The latest news and upcoming activities from the ADDIT-CE project.
- 20 short presentations (120 seconds each) from organizations working on diagnostics, therapies, care, digital solutions, and investment opportunities.
- The chance to showcase your own project or service in a concise and impactful 120-second pitch.
- A collaboration platform: find research partners, technology providers, investors, or care innovations.
- Insights into how you can contribute to and benefit from the ADDIT-CE network.
Program
- 2:30 PM – 3:00 PM | Registration
- 3:00 PM – 3:15 PM | Welcome & ADDIT-CE news
- 3:15 PM – 3:45 PM | 10 short presentations (120s pitches)
- 3:45 PM – 4:00 PM | Coffee & networking break
- 4:00 PM – 4:30 PM | 10 short presentations (120s pitches)
- 4:30 PM – 4:45 PM | Closing remarks
- 4:45 PM – 6:30 PM | Informal networking & matchmaking
Present your solution in 120 seconds
Are you developing a new technology, service, or research project related to Alzheimer’s, related dementias or other neurodegenerative diseases?
Do you provide care or support services for patients and families?
Do you want potential partners, investors, or healthcare providers to know about it?
This is your chance: introduce your work in 120 seconds and find collaborators.
Simply tick “I want to showcase at the event” in the registration form and include your presentation topic.
Who should attend?
- Researchers & clinicians
- Companies developing diagnostics, therapies, or digital solutions
- Care providers & NGOs
- Investors & funding organizations
- Students & innovators
- Anyone committed to advancing research, care, and innovation in Alzheimer's disease, related dementias, and other neurodegenerative diseases
About ADDIT-CE
ADDIT-CE is an international project focused on turning research findings into practical applications for the diagnosis, treatment, and care of people with Alzheimer’s disease and related dementias. Its mission: connect researchers, companies, healthcare providers, policymakers, and investors to create a strong innovation ecosystem in Central Europe.
This event has received funding from the European Union’s Horizon Europe program under Grant Agreement No. 101087124. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.
If you have any questions: events@multiplexdx.com
Register now and save a spot!
About MultiplexDX
MultiplexDX is one of the most innovative biotech corporations, created to bring its revolutionary technologies to the market of personalized molecular diagnostics. The company has representation in both U.S. and European markets. The collaborators of MultiplexDX are from the world’s most prestigious scientific organizations including the National Cancer Institute, Rockefeller University, Albert Einstein University, Vanderbilt University, Cornell University, Queens University (Canada), Hebrew University of Jerusalem (Israel), and the Max Delbrück Center for Molecular Medicine (Germany).
MultiplexDX IP-based and innovative platform merges histopathology methods, biomarker quantification, visualization and gene expression with a single-cell resolution by combining MDX proprietary visual and sequencing technologies into one diagnostic test. This cross-validation approach eliminates diagnostic errors and creates 100% precise cancer profiling for each patient which allows clinicians to suggest specific, personalized cancer treatment.
Find out more about MultiplexDX on Corporate website, Facebook, LinkedIn, Twitter
